What is AstaTech?
AstaTech Inc., headquartered in Bristol, Pennsylvania, has been a steadfast provider of specialized services to the pharmaceutical and biotechnology industries since its inception in 1996. The company's core competencies encompass custom synthesis, bulk manufacturing, and analytical services, complemented by an extensive catalog of chemical products. By integrating its deep chemistry expertise with robust economic manufacturing capabilities, AstaTech delivers cost-effective solutions tailored for drug discovery and development. Their client base primarily consists of global pharmaceutical and biotechnology firms seeking dependable and adaptable research and manufacturing partnerships.
How much funding has AstaTech raised?
AstaTech has raised a total of $759K across 2 funding rounds:
Debt
$350K
Debt
$409K
Debt (2020): $350K with participation from PPP
Debt (2021): $409K led by PPP
Key Investors in AstaTech
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for AstaTech?
The recent major strategic investment signals a pivotal growth phase for AstaTech, likely enabling the expansion of its service offerings, enhancement of its manufacturing capacities, and further penetration into global markets. This strategic backing is expected to fuel innovation in drug discovery and development solutions, reinforcing AstaTech's position as a key partner for pharmaceutical and biotech companies worldwide. The company's continued focus on high-quality, cost-effective services, combined with its established track record, positions it for sustained success and further enterprise-level development.
See full AstaTech company page
